(2Z)-N-[2,4-Dichloro-5-(propan-2-yloxy)phenyl]-1,3-thiazolidin-2-imine

Catalog No. :
ACFCFX426
CAS No. :
400736-23-4
Molecular Formula :
C12H14Cl2N2OS
Molecular Weight :
305.23

IUPAC Name:N-(2,4-dichloro-5-isopropoxyphenyl)-4,5-dihydrothiazol-2-amine

(2Z)-N-[2,4-Dichloro-5-(propan-2-yloxy)phenyl]-1,3-thiazolidin-2-imine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg90%$121.00Login to see priceInquiryInquiry
10mg90%$148.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2Z)-N-[2,4-Dichloro-5-(propan-2-yloxy)phenyl]-1,3-thiazolidin-2-imine
IUPAC NameN-(2,4-dichloro-5-isopropoxyphenyl)-4,5-dihydrothiazol-2-amine
MDL No.MFCD01316976
Molecular FormulaC12H14Cl2N2OS
Molecular Weight305.23
SMILESCC(OC1=C(Cl)C=C(Cl)C(/N=C2SCCN\2)=C1)C
InChI KeyVCVFHCBNICBHKL-UHFFFAOYSA-N
Synonym(2Z)-N-[2,4-dichloro-5-(propan-2-yloxy)phenyl]-1,3-thiazolidin-2-imine;2-Thiazolamine, N-[2,4-dichloro-5-(1-methylethoxy)phenyl]-4,5-dihydro-
CAS No.400736-23-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFCFX426 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKIQW295 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFCFX426 route product structure diagram
    ACFCFX426400736-23-4
Inquiry

2. ACFCFX426 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFCFX426 route product structure diagram
    ACFCFX426400736-23-4
Inquiry

Comments (0)